Purchase Order 36C25625P1282

Award Date 7/22/25
Potential Completion Date 9/22/25
Potential Value $84K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, for the delivery of various DNA sequencing products and services. The award, valued at $20,294.92, is a delivery order under Illumina's existing contracts with the Department of Veterans Affairs (VA), specifically a Blanket Purchase Agreement valued at $231,165 and an Indefinite Delivery Contract valued at $1,297,062. The contract covers the procurement of...
This federal contract award to Illumina, Inc. is for the delivery of DNA analysis kits. The contract, valued at $31,948.80, is a Blanket Purchase Agreement (BPA) call with the Department of Veterans Affairs (VA). Illumina, a leading provider of genetic sequencing and genomic analysis technologies, has been awarded this firm fixed price contract to supply the VA with its NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with associated reagents, consumables, maintenance services,...
This is a firm fixed price delivery order awarded to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the Veterinary Services division of the U.S. Department of Veterans Affairs. The $10,463.01 contract is for the provision of Illumina's sequencing instruments, reagents, consumables, and maintenance services, which support critical genomic research and diagnostic initiatives across various federal agencies. Illumina holds two notable Indefinite...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract worth $344,084.80 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. This order is not part of a set-aside program. Illumina will provide microarray kits to support genomic sequencing and analysis for research and diagnostics purposes at the agency. Illumina has previously provided a range of sequencing instruments,...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for the provision of microarray kits. The contract has a ceiling value of $997,972.18 and does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of Health (NIH), Centers for Disease...
This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by a civilian federal agency. The contract is for ISCAN SERVICES with a ceiling value of $26,481.25. It is a Blanket Purchase Agreement (BPA) Call contract with a firm fixed price pricing type. The contract does not have a set-aside designation. Illumina has also been awarded federal grant awards and multiple Indefinite Delivery Vehicles (IDVs) with the Department...
This is a firm fixed price delivery order issued by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $88,704.00 contract is for the provision of microarray kits. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to support genomic research and diagnostics across various federal agencies. This particular award does not have a set-aside designation....
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $88,704.00, is for the provision of microarray kits. Illumina has provided similar products and services to support genomic sequencing and analysis for research and diagnostics purposes across various federal agencies, including the National Institutes of Health, Centers for...
This federal contract award to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment and reagents, was issued by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 6. The $131,328.00 firm fixed price purchase order is for the delivery of Illumina assays and reagents to support genomic sequencing and analysis. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems,...
This is a federal contract award to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, by the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $22,274.30 and is a Blanket Purchase Agreement (BPA) call order, with a firm fixed price pricing type. The contract does not have a set-aside designation. Illumina is providing the VA with a range of its advanced sequencing instruments, reagents, consumables, and bioinformatics...

This is a federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, valued at $83,920.86, is a Firm Fixed Price Purchase Order from the Department of Veterans Affairs (VA), a civilian agency. The contract is not set aside and is for the provision of micro arrays. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs), including a $45 million contract with the U.S. Department of Agriculture (USDA) and a $231,165 Blanket Purchase Agreement with the VA, demonstrating the company's strategic position as a key technology provider for federal scientific and diagnostic research initiatives.

Generated 7/22/25, 9:59 AM